Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In a local lymph node assay, the sensitization potential of the natural oil monomer (i.e., methyl polyhydroxymethyl stearate or MPS) was evaluated in female CBA/J mice. Mice treated with 5%, 20%, or 80% NOM displayed stimulation indices of 2.0, 3.2, and 7.4 in comparison to vehicle-treated mice. The concentration that would cause a 3-fold increase in proliferation (EC3) was calculated to be 17.5%, which is consistent with weak dermal sensitization potential as described by an expert ECETOC panel (Technical Report No. 87, 2003).
The LLNA results for NOM were unexpected. NOM is derived from a fatty acid methyl ester (FAME) product prepared from natural seed oils. Review of the FAME products safety information with the manufacturer (MSDS and personal communication) indicates a lack of sensitization potential. Not only are fatty acids endogenous molecules, but fatty acids and FAME are commonly used to enhance dermal penetration for drug delivery (Chukwumerije, et al., 1989; Kogan and Garti, 2006), without outbreaks of sensitization in the population. With that said, there are spurious reports of sensitization for some fatty acid-like molecules [isopropyl myristate (Uter, et al., 2004; Bharati and King, 2004), glyceryl stearate (de Groot, et al., 1988), isopropyl palmitate (Lazzarini, 1982), retinyl/retinol palmitate (Clemmensen, et al., 2007; Manzano, et al., 1994)], but these appear to be disproportional in number compared to the degree of use.
Evaluation of NOM using TOPKAT, DEREK and OASIS programs did not demonstrate an alert for sensitization potential (unreported data - The Dow Chemical Company).
The natural oil monomer was incubated with liver S9 to represent a worst-case scenario in the skin. The resulting samples were analyzed for the formation of an aldehyde metabolite, methyl polyformyl stearate, the mostly likely reactive species to be derived from NOM. No aldehyde-containing metabolites were found to arise from in vitro metabolism of NOM.
A guinea pig M&K test was conducted and the first induction phase involved six intradermal injections into the suprascapular area of each of 20 guinea pigs using paired injections of the test substance in mineral oil (5% w/w), the test substance (5% w/w) combined with Complete Freund's Adjuvant as well as Complete Freund's Adjuvant alone. Approximately one week later, the second phase of induction applied undiluted MPS topically for a period of 48 hours to the area encompassing the intradermal injection sites. Subsequent topical challenge using 6% NOM did not elicit evidence for sensitization potential.
The expression of relevant lymphocyte surface markers (B220+) and mouse ear swelling responses following previous dermal induction was evaluated. The results of the B220+ assay suggest that the proliferative response tomethyl polyhydroxymethyl stearate in the draining lymph node is consistent with that of a chemical having skin sensitizing potential. Similarly, the MEST demonstrated ear swelling upon specific challenge with MPS that was indicative of a sensitization response. The B220+ and MEST responses following topical treatments with MPS are generally consistent with the mouse LLNA. These studies in mice, collectively, suggest that methyl polyhydroxymethyl stearate may possess weak dermal sensitization potential.
Migrated from Short description of key information:
The concentration that would cause a 3-fold increase in proliferation (EC3) was calculated to be 17.5%, which is consistent with weak dermal sensitization potential as described by an expert ECETOC panel (Technical Report No. 87, 2003).
Justification for classification or non-classification
NOM demonstrates a somewhat inconsistent profile, but may possess weak for dermal sensitisation potential (R43). The substances has no evidence to suggest that it should be classified for respiratory sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.